- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04567108
Health Effects of Substituting Sugary Beverages With Artificially-sweetened Beverages or Water (SUB-POP)
SUBstituting With Preferred Options: Health Effects of Substituting Sugar-sweetened Beverages With Non-caloric Beverages in Adults With Overweight and Obesity
Study Overview
Status
Conditions
Detailed Description
The SUBstituting with Preferred OPtions (SUB-POP) trial, is a parallel-arm randomized controlled trial (RCT) to test the effects of substituting SSBs with non-caloric options on body weight and markers of type 2 diabetes and cardiometabolic health. Eligible adult participants will be randomized to 1 of 4 beverage groups and receive at-home monthly deliveries of beverages for 6 months. In-person clinic visits will be conducted at baseline, 6, and 12 months. After the 6 months of assigned beverage substitution and delivery, all participants will be instructed to substitute SSBs with water only for a final 6-month observational period. In-person clinic visits will collect technician-measured anthropometrics, blood pressure, biospecimen samples (blood, urine, stool [subset]), and assess physical activity, diet, beverage frequency, and taste preference. The SUB-POP app-based assessments and online diet recall will ascertain daily beverage intake, while diet (via 3 24-hour recalls), physical activity, and overall beverage frequency will be collected every 1-3 months. A subset will receive at-home digital scales to transmit daily body weight for energy balance and caloric compensation modeling. SUB-POP is a novel RCT that will enroll adult regular SSB consumers with overweight or obesity to evaluate the effectiveness of substituting SSBs with non-caloric options in a real-world, un-blinded setting. The trial will leverage social media recruitment methods, achieve ≥30% non-White participants, implement innovative intervention delivery, adherence, and data collection tools, and partition the artificially-sweetened beverage (ASB) substitution intervention to the two most common artificial sweetener types (aspartame, sucralose) to explore potential heterogeneity. Whether ASBs, which are largely free of calories and sugar, provide a healthful interim strategy to transition to water among habitual SSB consumers is unknown. Thus, by addressing this large gap in the understanding of how to address a highly prevalent and concerning dietary exposure, the investigators will inform dietary guidelines and clinical recommendations for the prevention of obesity, type 2 diabetes, and cardiometabolic disease risks. The primary outcomes are change in body weight from baseline to 6 months between the 3 beverage substitution groups (aspartame ASBs, sucralose ASBs, and water) vs. the maintain SSBs control group, adjusting for multiple comparisons. The investigators and staff will be blinded to group assignment at outcome assessments. Intention-to-treat analysis will be used.
After 9/1/2023 the 2 ASB intervention groups (sucralose, aspartame) are combined into a single ASB intervention group; participants randomized on or after 9/1/2023 will be randomized to 1 of 3 beverage groups: maintain SSBs (months 0-6; then switch to water months 6-12); switch to ASBs (months 0-6; then switch to water months 6-12); switch to water (months 0-12). The primary outcomes are change in body weight from baseline to 6 months between the 2 beverage substitution groups (ASBs [all ASB intervention groups combined] and water) vs. the maintain SSBs control group, adjusting for multiple comparisons.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Brigham and Women's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults aged 20-69 years
- Consume ≥1 serving/day (12 oz.) of SSBs (SSBs include soda, fruit drinks, energy drinks, sports drinks, and sweetened waters, sweetened with high fructose corn syrup, sucrose, or fruit juices. SSBs do not include 100% fruit juice, sweetened teas, or flavored milk.)
- BMI 25.0 to 45.0 kg/m2
- Access to a smartphone and willingness and ability to download study app
- Willing to consume beverages consistent with any of the 4 possible group assignments for 6 months
Exclusion Criteria:
- Physician diagnosis of T2D or fasting glucose ≥126 mg/dL at in-person screening visit
- Intention to move away from greater Boston area within 1 year from randomization
- Major medical illness (known cardiovascular disease, cancer, kidney disease, cirrhosis, etc.)
- Phenylketonuria (PKU)
- Medication that may affect weight or other study endpoints
- Another family or household member participating in the study
- Pregnant in the past 12 months, currently breastfeeding, or planning to become pregnant during the study period
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Maintain SSBs (Control)
Instruction to maintain baseline intake of SSBs (months 0-6); then switch to water only (months 6-12)
|
Instruction/guidelines to maintain baseline intake of SSBs (months 0-6); then switch to water only (months 6-12)
Engage with a motivational mobile app to track beverage intake and complete study data collection
Select from approved beverages for a monthly at-home delivery (months 0-6)
|
|
Experimental: Substitute Aspartame ASBs (participants randomized through 8/31/2023)
Instruction/guidelines to eliminate SSBs and replace, where possible with beverages artificially sweetened with aspartame (months 0-6); then switch to water only (months 6-12)
|
Engage with a motivational mobile app to track beverage intake and complete study data collection
Select from approved beverages for a monthly at-home delivery (months 0-6)
Instruction/guidelines to eliminate SSBs and replace, where possible, with beverages consistent to group assignment (months 0-6); then switch to water only (months 6-12)
|
|
Experimental: Substitute Sucralose ASBs (participants randomized through 8/31/2023)
Instruction/guidelines to eliminate SSBs and replace, where possible with beverages artificially sweetened with sucralose (months 0-6); then switch to water only (months 6-12)
|
Engage with a motivational mobile app to track beverage intake and complete study data collection
Select from approved beverages for a monthly at-home delivery (months 0-6)
Instruction/guidelines to eliminate SSBs and replace, where possible, with beverages consistent to group assignment (months 0-6); then switch to water only (months 6-12)
|
|
Experimental: Substitute Water
Instruction/guidelines to eliminate SSBs and replace with water (months 0-12)
|
Engage with a motivational mobile app to track beverage intake and complete study data collection
Select from approved beverages for a monthly at-home delivery (months 0-6)
Instruction/guidelines to eliminate SSBs and replace, where possible, with beverages consistent to group assignment (months 0-6); then switch to water only (months 6-12)
|
|
Experimental: Substitute ASBs (participants randomized on or after 9/1/2023)
Instruction/guidelines to eliminate SSBs and replace, where possible with beverages artificially sweetened with choice of non-nutritive sweeteners such as sucralose or aspartame
|
Engage with a motivational mobile app to track beverage intake and complete study data collection
Select from approved beverages for a monthly at-home delivery (months 0-6)
Instruction/guidelines to eliminate SSBs and replace, where possible, with beverages consistent to group assignment (months 0-6); then switch to water only (months 6-12)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight Change at 6 months
Time Frame: Baseline, Month 6
|
Change in total body weight calculated as the month 6 weight minus the baseline weight
|
Baseline, Month 6
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Waist Circumference Change
Time Frame: Baseline, Month 6
|
Calculated as month 6 minus baseline value
|
Baseline, Month 6
|
|
Sussex Sweet Taste Preference Score Change (0 to 100 where higher score indicates greater liking of sweet taste)
Time Frame: Baseline, Month 6
|
Calculated as month 6 minus baseline value
|
Baseline, Month 6
|
|
Beverage Intake Change (oz/d)
Time Frame: Baseline, Month 6
|
Calculated as month 6 minus baseline value
|
Baseline, Month 6
|
|
Fasting Plasma Glucose Change
Time Frame: Baseline, Month 6
|
Calculated as month 6 minus baseline value
|
Baseline, Month 6
|
|
Fasting Blood Insulin Change
Time Frame: Baseline, Month 6
|
Calculated as month 6 minus baseline value
|
Baseline, Month 6
|
|
HOMA-IR Change
Time Frame: Baseline, Month 6
|
Calculated as month 6 minus baseline value
|
Baseline, Month 6
|
|
HbA1c Change
Time Frame: Baseline, Month 6
|
Calculated as month 6 minus baseline value
|
Baseline, Month 6
|
|
TG/HDL Ratio Change
Time Frame: Baseline, Month 6
|
Calculated as month 6 minus baseline value
|
Baseline, Month 6
|
|
Weight Change Sustainability
Time Frame: Baseline, Month 6
|
Calculated as month 6 minus baseline value, month 12 minus month 6 value
|
Baseline, Month 6
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Waist Circumference Change
Time Frame: Baseline, Month 6, Month 12
|
Calculated as month 6 minus baseline value, month 12 minus month 6 value
|
Baseline, Month 6, Month 12
|
|
Sussex Sweet Taste Preference Score Change (0 to 100 where higher score indicates greater liking of sweet taste)
Time Frame: Baseline, Month 6, Month 12
|
Calculated as month 6 minus baseline value, month 12 minus month 6 value
|
Baseline, Month 6, Month 12
|
|
Total Beverage Intake Change (oz/d)
Time Frame: Baseline, Month 6, Month 12
|
Calculated as month 6 minus baseline value, month 12 minus month 6 value
|
Baseline, Month 6, Month 12
|
|
SSB Beverage Intake Change (oz/d)
Time Frame: Baseline, Month 6, Month 12
|
Calculated as month 6 minus baseline value, month 12 minus month 6 value
|
Baseline, Month 6, Month 12
|
|
ASB Beverage Intake Change (oz/d)
Time Frame: Baseline, Month 6, Month 12
|
Calculated as month 6 minus baseline value, month 12 minus month 6 value
|
Baseline, Month 6, Month 12
|
|
Water Intake Change (oz/d)
Time Frame: Baseline, Month 6, Month 12
|
Calculated as month 6 minus baseline value, month 12 minus month 6 value
|
Baseline, Month 6, Month 12
|
|
HOMA-IR Change
Time Frame: Baseline, Month 6, Month 12
|
Calculated as month 6 minus baseline value, month 12 minus month 6 value
|
Baseline, Month 6, Month 12
|
|
Fasting Blood Insulin Change
Time Frame: Baseline, Month 6, Month 12
|
Calculated as month 6 minus baseline value, month 12 minus month 6 value
|
Baseline, Month 6, Month 12
|
|
Fasting Plasma Glucose Change
Time Frame: Baseline, Month 6, Month 12
|
Calculated as month 6 minus baseline value, month 12 minus month 6 value
|
Baseline, Month 6, Month 12
|
|
HbA1c Change
Time Frame: Baseline, Month 6, Month 12
|
Calculated as month 6 minus baseline value, month 12 minus month 6 value
|
Baseline, Month 6, Month 12
|
|
Triglycerides Change
Time Frame: Baseline, Month 6, Month 12
|
Calculated as month 6 minus baseline value, month 12 minus month 6 value
|
Baseline, Month 6, Month 12
|
|
TG/HDL Change
Time Frame: Baseline, Month 6, Month 12
|
Calculated as month 6 minus baseline value, month 12 minus month 6 value
|
Baseline, Month 6, Month 12
|
|
HDL-C Change
Time Frame: Baseline, Month 6, Month 12
|
Calculated as month 6 minus baseline value, month 12 minus month 6 value
|
Baseline, Month 6, Month 12
|
|
LDL-C Change
Time Frame: Baseline, Month 6, Month 12
|
Calculated as month 6 minus baseline value, month 12 minus month 6 value
|
Baseline, Month 6, Month 12
|
|
Blood Pressure (Systolic and Diastolic) Change
Time Frame: Baseline, Month 6, Month 12
|
Calculated as month 6 minus baseline value, month 12 minus month 6 value
|
Baseline, Month 6, Month 12
|
|
hsCRP Change
Time Frame: Baseline, Month 6, Month 12
|
Calculated as month 6 minus baseline value, month 12 minus month 6 value
|
Baseline, Month 6, Month 12
|
|
Interleukin-6 Change
Time Frame: Baseline, Month 6, Month 12
|
Calculated as month 6 minus baseline value, month 12 minus month 6 value
|
Baseline, Month 6, Month 12
|
|
Alternative Healthy Eating Index 2015 Diet Score Change (Scale 0 to 100 with higher score indicating greater adherence to the dietary pattern)
Time Frame: Baseline, Month 6, Month 12
|
Calculated as month 6 minus baseline value, month 12 minus month 6 value
|
Baseline, Month 6, Month 12
|
|
Self-Reported Added Sugar Change (g/d from 24 hour diet recall)
Time Frame: Baseline, Month 6, Month 12
|
Calculated as month 6 minus baseline value, month 12 minus month 6 value
|
Baseline, Month 6, Month 12
|
|
Self Reported Added Sugar Change (%kcal/d from 24 hour diet recall)
Time Frame: Baseline, Month 6, Month 12
|
Calculated as month 6 minus baseline value, month 12 minus month 6 value
|
Baseline, Month 6, Month 12
|
|
Sweets/Desserts Change (serv/d from 24 hour diet recall)
Time Frame: Baseline, Month 6, Month 12
|
Calculated as month 6 minus baseline value, month 12 minus month 6 value
|
Baseline, Month 6, Month 12
|
|
Total Physical Activity Change (MET-hrs/wk)
Time Frame: Baseline, Month 6, Month 12
|
Calculated as month 6 minus baseline value, month 12 minus month 6 value
|
Baseline, Month 6, Month 12
|
|
Energy Compensation (kcal/d) Estimated from Repeated Body Weights (Assessed via At-Home Scale) vs. Repeated Energy Intake (Derived from Repeated Self-Reported 24-Hour Diet Recalls)
Time Frame: Baseline, Month 6, Month 12
|
Calculated as month 6 minus baseline value, month 12 minus month 6 value
|
Baseline, Month 6, Month 12
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Deirdre Tobias, ScD, Brigham and Women's Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020p002494
- 1R01DK125803-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Body Weight
-
Oslo University HospitalMayo Clinic; Sorlandet Hospital HF; The Hospital of Vestfold; University of TwenteActive, not recruiting
-
Fred Hutchinson Cancer CenterCompletedWeight Loss | Weight, BodyUnited States
-
Pusan National University HospitalCompletedWeight Change, Body
-
Xinhua Hospital, Shanghai Jiao Tong University...Not yet recruiting
-
Erik Ramirez LopezCompletedWeight Loss | Body CompositionMexico
-
University of TennesseeMayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases...CompletedSmoking Cessation | Weight Change, BodyUnited States
-
Virta HealthCompleted
-
University of CopenhagenCompleted
-
North Dakota State UniversityThe Cleveland Clinic; Neuropsychiatric Research InstituteUnknown
-
University of LeedsDietary Assessment LtdCompletedWeight Loss | Colorectal Surgery | Weight Change, Body | Gastroenterology SurgeryUnited Kingdom
Clinical Trials on Maintain usual SSBs
-
Instituto Nacional de Ciencias Medicas y Nutricion...CompletedObesity and OverweightMexico
-
National Institute of Diabetes and Digestive and...The Cleveland ClinicCompletedChronic Renal Disease
-
University of TorontoUnknownCardiovascular Diseases | Mortality | Metabolic Syndrome | Type 2 Diabetes | AdiposityCanada
-
Outcomes'10Active, not recruitingAnticoagulated PatientsSpain
-
Hoffmann-La RocheCompleted
-
Centre Hospitalier le MansRecruitingCardiac Arrest | Out-of-hospital Cardiac Arrest (OHCA)France
-
National Taiwan University HospitalActive, not recruitingHypotension During SurgeryTaiwan
-
Hoffmann-La RocheTerminated
-
Johns Hopkins UniversityNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingOverweight and Obesity | Behavior, Health | Postpartum Weight Retention | Pregnancy Weight GainUnited States
-
University Hospital, AngersCompletedMortality | Septic Shock | Hemodynamics | Clinical Trial | Arterial PressureFrance